MRC Epidemiology Unit - Publications Database

Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancers.

Smith-Byrne K, Hedman Å, Dimitriou M, Desai T, Sokolov AV, Schioth HB, Koprulu M, Pietzner M, Langenberg C, Atkins J, Penha RC, McKay J, Brennan P, Zhou S, Richards BJ, Yarmolinsky J, Martin RM, Borlido J, Mu XJ, Butterworth A, Shen X, Wilson J, Assimes TL, Hung RJ, Amos C, Purdue M, Rothman N, Chanock S, Travis RC, Johansson M, Malarstig A

Nature communications. Apr 2024

(DOI : 10.1038/s41467-024-46834-3)

Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement.

Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, VanderWeele TJ, Higgins JPT, Timpson NJ, Dimou N, Langenberg C, Golub RM, Loder EW, Gallo V, Tybjaerg-Hansen A, Davey Smith G, Egger M, Richards JB

JAMA. Oct 2021

(DOI : 10.1001/jama.2021.18236)

Circulating Selenium and Prostate Cancer Risk: A Mendelian Randomization Analysis.

Yarmolinsky J, Bonilla C, Haycock PC, Langdon RJQ, Lotta LA, Langenberg C, Relton CL, Lewis SJ, Evans DM, PRACTICAL Consortium, Davey Smith G, Martin RM

Journal of the National Cancer Institute. Nov 2017

(DOI : 10.1093/jnci/djy081)